These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 7600138

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G, Di Lorenzo G, Soldini M, Marziali M, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Barbarini G.
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [Abstract] [Full Text] [Related]

  • 3. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC, Schalm SW, Meulstee J, Stijnen T.
    Gastroenterol Clin Biol; 1995 Jun; 19(6-7):572-80. PubMed ID: 7590022
    [Abstract] [Full Text] [Related]

  • 4. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Barbarini G.
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 7. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
    Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, de Sá MF.
    Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
    Abid S, Jafri W, Mumtaz K, Islam M, Abbas Z, Shah HA, Hamid S.
    J Coll Physicians Surg Pak; 2011 Nov; 21(11):666-71. PubMed ID: 22078345
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, Rampello L.
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
    Laccetti M, Manes G, Uomo G, Lioniello M, Rabitti PG, Balzano A.
    Dig Liver Dis; 2000 May; 32(4):335-8. PubMed ID: 11515632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.
    Groeneweg M, Gyr K, Amrein R, Scollo-Lavizzari G, Williams R, Yoo JY, Schalm SW.
    Electroencephalogr Clin Neurophysiol; 1996 Jan; 98(1):29-34. PubMed ID: 8689991
    [Abstract] [Full Text] [Related]

  • 18. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial.
    Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM.
    Am J Gastroenterol; 2007 Apr; 102(4):744-53. PubMed ID: 17222324
    [Abstract] [Full Text] [Related]

  • 19. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D, Tahiri C, Lanchier C, Navelet Y, Durand P, Rousset A.
    Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
    [Abstract] [Full Text] [Related]

  • 20. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?
    Cadranel JF, Lebiez E, Di Martino V, Bernard B, El Koury S, Tourbah A, Pidoux B, Valla D, Opolon P.
    Am J Gastroenterol; 2001 Feb; 96(2):515-8. PubMed ID: 11232699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.